Cardiovascular Sciences, Inc. (CVSC) Stock

About Cardiovascular Sciences, Inc.

Cardiovascular Sciences Inc. (CVSC) is an innovative technology enterprise dedicated to advancing healthcare through the development of specialized medical products. Its diverse portfolio includes cutting-edge solutions designed to address critical cardiovascular and surgical needs. These include: Anti Adhesion Technology, aimed at minimizing post-surgical scarring; its proprietary Pyruvate Therapy, a unique therapeutic method for individuals experiencing cardiac trauma such as ischemic reperfusion injury, heart failure, and complications from bypass surgery; a Thromboresistant Coating that inhibits blood clot formation on medical devices; an advanced, biocompatible Human Vascular Tissue Equivalent for arterial replacement during heart operations; and its patented line of Aortic Catheters. The company, headquartered in Orlando, Florida, underwent a name change in May 2006, transitioning from its former identity as Beverly Hills Weight Loss and Wellness, Inc. to Cardiovascular Sciences, Inc.

Cardiovascular Sciences, Inc. (CVSC) stock trades at $0.00 with a market capitalization of $1696. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

Official website: www.cvsciences.org